Structured evidence table for Panax Ginseng Cognitive Performance Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Panax Ginseng Cognitive Performance Randomized Trial | Growing evidence suggests that neuroinflammation plays a crucial role in ET pathogenesis (Mattson and Camandola; Muruzheva, Ivleva, et al.). | 4 | Soti Monavareh (2026) | Korean Red Ginseng Attenuates Dysfunctions and Modulates Inflammatory and Neuroplasticity Markers in the Harmaline‐Induced Model of Essential Tremor |
| Panax Ginseng Cognitive Performance Randomized Trial | 2016 Fear‐associated learning and memory were evaluated using a two‐compartment passive avoidance system, comprising illuminated and darkened chambers connected by a guillotine‐type door. | 4 | Soti Monavareh (2026) | Korean Red Ginseng Attenuates Dysfunctions and Modulates Inflammatory and Neuroplasticity Markers in the Harmaline‐Induced Model of Essential Tremor |
| Panax Ginseng Cognitive Performance Randomized Trial | Importantly, the Harmaline + Ginseng group showed markedly reduced tremor intensity compared to the Harmaline group on Days 3 and 5 (< 0.01) (Figure ), suggesting that treatment with Korean red Ginseng attenuated Harmaline‐induced tremor. | 4 | Soti Monavareh (2026) | Korean Red Ginseng Attenuates Dysfunctions and Modulates Inflammatory and Neuroplasticity Markers in the Harmaline‐Induced Model of Essential Tremor |
| Panax Ginseng Cognitive Performance Randomized Trial | 2021 2022 2018 Essential tremor (ET) is one of the most prevalent adult‐onset movement disorders, affecting over 1% of the general population and more than 5% of individuals over 65 years of age (Louis and McCreary). | 4 | Soti Monavareh (2026) | Korean Red Ginseng Attenuates Dysfunctions and Modulates Inflammatory and Neuroplasticity Markers in the Harmaline‐Induced Model of Essential Tremor |
Source documents